Conference Schedule Thursday, October 13 Stress and Addiction 8:30 am Welcome and introduction David Kan, MD, Conference Chair; Medical Director, Opiate Replacement Therapy Clinic, San Francisco VA Medical Center; Assistant Clinical Professor, UC San Francisco 8:40 am How stress promotes relapse and jeopardizes recovery: Implications for new treatments in addiction Rajita Sinha, PhD, Professor of Psychiatry and Child Study; Director, Yale Interdisciplinary Stress Center, Yale University School of Medicine, New Haven, CT 9:35 am Stress and medical co-morbidities David Pating, MD, Chief, Addiction Medicine, Kaiser San Francisco Medical Center 10:15 am Break with exhibitors 10:35 am Stress, coping, and addiction among returning veterans Jeffery Wilkins, MD, Vice Chair of the Department of Psychiatry and Behavioral Neurosciences and Medical Director of Addiction Medicine and Director of Addiction Studies, Cedars-Sinai, Los Angeles 11:15 am Panel 12:00 noon Lunch on your own Health care reform: what the future holds for addiction physicians 1:30 pm Things will change: health care reform is insurance reform David Pating, MD, Chief, Addiction Medicine, Kaiser San Francisco Medical Center 1:50 pm Presentation of Vernelle Fox Award to David Pating, MD 2:00 pm Presentation of the Community Service Award to Harriet Rossetto and Rabbi Mark Borovitz Health care reform: what CSAM physicians need to do NOW H. Westley Clark, MD, JD, MPH, Director, Center for Substance Abuse Treatment (CSAT) 2:20 pm Your future practice: ingredients of health care reform. Thomas Freese, PhD, UCLA Integrated Substance Abuse Program 2:50 pm Break with exhibitors 3:05 pm Am I ready? A case study P. Joseph Frawley, MD, private practice of Addiction Medicine and Internal Medicine, Santa Barbara 3:20 pm Readiness assessment panel 3:40 pm Three examples of health care reform in action Judith Martin, MD, Medical Director, BAART Turk Street Clinic, San Francisco Sharone Abramowitz, MD, Director, Behavioral Medicine Primary Care Medicine Faculty, Alameda County Medical Center (UCSF Affiliate) Steven Shoptaw, PhD, Professor, UCLA Departments of Family Medicine and Psychiatry and Biobehavioral Sciences 4:30 pm Questions and Panel 5:00 pm Adjourn for the day 7:30 pm Dessert Reception (free to registrants and guests) A Life in Addiction Medicine Speaker: Garrett O'Connor MD, Chief Executive Officer of the Betty Ford Institute Friday, October 14 8:30 am Latest Research on opioid receptors: implications for treatment Francis Vocci, PhD, President, Friends Research Institute, Baltimore, MD 9:15 am The amygdala, novelty and the endocannabinoid system Timmen Cermak, MD, President, CSAM; Psychiatrist in private practice, Mill Valley and San Francisco, CA 9:50 am Cannabis Use Disorders in Adolescents and Young Adults: What Clinicians Need to Know Paula Riggs, MD, Professor of Psychiatry, University of Colorado, Denver 10:35 am Break with exhibitors 10:55 am When Guidelines Fail... Treating Co-Morbid, High-Risk Tobacco Addicts Linda Hyder Ferry, MD, MPH, Chief, Preventive Medicine, Loma Linda Veterans Affairs Medical Center; Associate Professor, Loma Linda University School of Medicine and School of Public Health, Loma Linda, CA 11:35 am Technology-Based Interventions for the Prevention and Treatment of Substance Use Disorders Lisa Marsch, PhD, Director, Center for Technology and Health, National Development and Research Institute, New York 12:30 pm Lunch on your own 12:30 pm CSAM Annual Business Meeting After the War on Drugs: Law, Policy, and Treatment 2:00 pm Treatment and criminal justice intervention: what works? Michael Prendergast, PhD, Director of Criminal Justice Research Group at the UCLA Integrated Substance Abuse Programs (ISAP) 2:30 pm The Project-based housing first approach for chonically homeless individuals with alcohol problems Susan Collins, PhD, Research Assistant Professor, Department of Psychiatry and Behavioral Sciences
University of Washington at Harborview Medical Center 3:00 pm Portuguese drug decriminalization: outcomes F�tima Trigueiros, Advisor to the Executive Board, Institute for Drugs and Drug Addiction, Portugal 3:50 Break with exhibitors 4:10 Cannabis legalization: implications for California Beau Kilmer, PhD, Co-director of the RAND Drug Policy Research Center, Santa Monica, CA 4:35 An Evidence-Based Proposal for Drug Abuse Policy Peter Banys, MD, MSc, Chief of Substance Abuse, San Francisco VA Medical Center, and Clinical Professor of Psychiatry , UC San Francisco Timmen Cermak, MD, President, CSAM; Psychiatrist in private practice, Mill Valley and San Francisco, CA 4:55 Panel with all speakers 5:20 Adjourn for the day Saturday, October 15 8:30 am Medications in the pipeline Francis Vocci, PhD, President, Friends Research Institute, Baltimore, MD 9:10 am Psychopharmacology of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics Lara Ray, PhD, Assistant Professor, Department of Psychology and Brain Research Institute, UCLA 9:55 am New medications for hepatitis C Anthony Albanese, MD, Director, Chemical Dependency Division and Director, Hepatitis C Program, VA Medical Center, Mather, CA; Clinical Associate Professor of Medicine at UC Davis 10:20 am Break 10:35 am Fetal alcohol spectrum disorders, the hidden disability: evaluation and treatment Adjunct Professor, Department of Psychiatry at the David Geffen School of Medicine at UCLA 11:10 am Intrauterine Abstinence Syndrome (IAS) from buprenorphine inductions and methadone tapers: are we ignoring the safety of the fetus? John J. McCarthy, MD, Executive/Medical Director Bi-Valley Medical Clinic, Sacramento, CA; Assistant Professor of Psychiatry UC Davis 11:45 am Emerging drugs of abuse: a clinical diagnostic and treatment perspective Silas Wheelock Smith, MD, Assistant Professor, Departments of Emergency Medicine, New York University School of Medicine 12:30 pm Adjourn